Upper limb motor control training for cognitive function in older adults
The Effect of Upper Limb Low-intensity Motor Control Training (uMCON) Program on Cognitive Function in Healthy Older Adults: A Pilot Study
NA · University of Nottingham · NCT06962722
This study is testing if a special training program for arm movements can help healthy older adults improve their physical skills and thinking abilities.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 24 (estimated) |
| Ages | 65 Years to 85 Years |
| Sex | All |
| Sponsor | University of Nottingham (other) |
| Locations | 1 site (Derby, Derbyshire) |
| Trial ID | NCT06962722 on ClinicalTrials.gov |
What this trial studies
This intervention study evaluates the effectiveness of upper limb motor control training (uMCT) on both physical and cognitive functions in healthy older adults aged 65-85. Participants will be randomized into either the uMCT group or a no-intervention control group, with assessments conducted before and after a 4-week training period. The study aims to determine if uMCT can enhance motor coordination, neuromuscular function, and cognitive abilities while also assessing the feasibility and safety of the training program. Participants will undergo screening and assessment sessions to ensure their eligibility and safety throughout the study.
Who should consider this trial
Good fit: Ideal candidates are healthy older adults aged 65-85 who are willing to participate and provide informed consent.
Not a fit: Patients with diagnosed cognitive impairment or significant medical conditions such as cardiovascular or neurological diseases may not benefit from this study.
Why it matters
Potential benefit: If successful, this training program could improve cognitive and physical functions in older adults, potentially enhancing their quality of life.
How similar studies have performed: While similar approaches have been explored, this specific intervention focusing on upper limb motor control training in healthy older adults is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * • Willing and able to give informed consent for participation in the study * Aged between 65-85 years Exclusion Criteria: * • Diagnosis of cognitive impairment * Current or recent (\<5y) malignancy * History of or current psychiatric illness * History of or current neurological condition (e.g., epilepsy, Parkinsons disease, cerebrovascular disease) * Severe respiratory disease (e.g., uncontrolled asthma, COPD, pulmonary hypertension) * Active cardiovascular disease: Uncontrolled hypertension (BP\>160/100mmHg); Recent (\<12mo) cardiac event; Heart failure (Class III/IV); Significant arrhythmia; Unstable angina * Metabolic disease: Untreated hyper/hypo-parathyroidism; Cushing's disease; Type 1 or 2 diabetes * Significant musculoskeletal disorders (based on clinical opinion) * Family history of early (\<55y) death from cardiovascular disease
Where this trial is running
Derby, Derbyshire
- The University of Nottingham Medical School — Derby, Derbyshire, United Kingdom (RECRUITING)
Study contacts
- Study coordinator: Bethan E Phillips, Professor
- Email: beth.phillips@nottingham.ac.uk
- Phone: 01332 724676
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Cognitive Impairment, neuromuscular training, older adults, cognitive impairment, exercise